Results Mean post-operative best-corrected visual acuity in group I was significantly lower (20/37.38) We use flexible open-loop one-piece AC-IOLs when the posterior capsule or its remnants cannot support the lens. In this study we assessed and compared the outcomes of primary and secondary implantation of these lenses.
Material and methods
This retrospective study, spanning December 1993 to January 1997, evaluated the results of AC-IOL implantation in two groups. In group I (n = 35 eyes of 34 patients), an AC-IOL was implanted primarily in cataract surgery because of posterior capsule complications encountered during ECCE. Capsule complications in this group included 32 (91 %) posterior capsule ruptures and vitreous loss and 3 (9%) zonular dialyses. In all cases with vitreous loss, vitrectomy was performed by a Kaufmann vitrector or sponge-and-scissors. The eyes that received a PC-IOL after vitreous loss are not included. Thirty-four Ophtec AC260T AC-IOLs (Ophtec, Groningen, Holland) and one Hanita OPAB16 AC-IOL (Kibbutz, Hanita, Israel), which all are one-piece PMMA lenses, were implanted in this group. All eyes were followed for at least 12 months (range 12-38 months).
In group II there were 22 aphakic eyes of 22 patients that had all had previous ICCE surgery elsewhere. All eyes received an Ophtec AC260T IOL. The size of the AC-IOL to be implanted was determined by adding 1 mm to the horizontal white-to-white iris diameter. A lens guide was used to prevent iris tuck and uveal chafing in all cases. Time between cataract extraction and secondary IOL implantation ranged from 11 months to 6 years (mean 2.8 years). An anterior vitrectomy was performed in 10 cases of this group to remove all formed vitreous from the anterior chamber. All eyes were followed for at least 12 months (range 12-31 months).
Patient age at surgery ranged from 18 to 85 years (average 63.3 years) in group I and from 18 to 79 years (average 61.3 years) in group II.
Results
Six patients in group I and one in group II had significantly decreased vision for reasons unconnected with the surgery: retinitis pigmentosa (2 cases), age related macular degeneration (1 case in each group), diabetic maculopathy (1 case), glaucomatous optic atrophy (1 case) and post-traumatic vitreoretinopathy (1 case). In analysing visual outcomes these cases were excluded.
Mean best corrected visual acuity (VA) in group I was 20/37. Table 1 shows the complications encountered. In group I, 17 eyes (49%) had a total of 22 complications, while 7 eyes (32%) had 9 complications in group II. Although group II had a markedly lower complication rate, the difference between the groups was not statistically significant (chi-squared test, p > 0.05). No cases of explantation, loop malplacement, retinal Nineteen of 29 eyes (65%) in our primary implantation group (group I) achieved a best corrected V A of 20/40 or better. This result is comparable with previous studies. In the literature this good V A level has been reported in from 35% to 82% of primary implantations.s, 6, [13] [14] [15] In terms of VA results, the cases that had secondary IOL insertion following uncomplicated ICCE had more favourable outcomes than the cases with primary IOL implantation that underwent complicated ECCE. These results are consistent with those of David et a/.13 They reported that 56% of eyes with secondary implantation following uncomplicated ICCE achieved a good VA (20/40 or better), compared with 35% of cases that underwent complicated ECCE. In our study, this lower rate of good VA in primary cases was associated with the complicated surgery, and it may be due to prolonged surgical time and increased inflammation.
The percentage of eyes achieving a final V A equal to or better than their best corrected pre-operative VA was 86% in group II. This is consistent with those previous studies that reported a high rate of good vision. [5] [6] [7] [16] [17] [18] [19] The reduction in best corrected VA may be due to cystoid macular oedema, although that was not clearly diagnosed in this group.
In this study there were no serious per-operative problems in either group. Sight-threatening complications consisted of cystoid macular oedema (2 in group I and 1 in group II), 1 secondary glaucoma in group I, and 1 pseudophakic bullous keratopathy in group I. Both the severe and total complication rates were higher in group I, and this was associated with a higher vitreous loss rate that necessitated vitrectomy and prolonged the surgery time. Eyes undergoing primary AC-IOL implantation are already at a significantly greater risk of cystoid macular oedema, retinal detachment and post-operative inflammatory glaucoma. Patients undergoing secondary AC-IOL implantation are (14) 1 (3) 1 (3) 22 (63) 17 (49) 3 (14) 5 (23) 1 (4) 9 (41) 7 (32) presumably a healthier group of eyes that have been pre selected on the basis of their visual potential, and absence of inflammation, glaucoma or anterior chamber abnormalities including peripheral anterior synechiae. In their study, David et al. 13 found lower rates of cystoid macular oedema and pseudophakic bullous keratopathy in the secondary implantation group. Weene5 also reported no retinal complications in secondary implantation cases. He proposed that this might be due to the vitreous liquefaction and posterior detachment that occurs in most cases of aphakia, especially after 1 year. 5, 20 This may explain why the results of secondary implantation are better when 1 or more years have elapsed after cataract surgery, as was the case in the current series. 21 The complications in the secondary implantation group, such as intraoperative haemorrhage, pupil deformation and cystoid macular oedema, may be related to sizing and placement of the lens implant rather than the presence of the lens itself.
Because of the high complication rate and explantation rate of first-generation closed-loop AC-IOLs,22 some surgeons advocate implanting scleral fixated PC-IOLs and not using AC-IOLs in the absence of a posterior capsular support.3,23-25 In their prospective comparative study, however, Bellucci et aZ? found a higher complication rate in scleral-fixated lenses than in open-loop AC-IOLs. The surgical technique of scleral fixated lenses requires elaborate skills and aggressive intraocular manipulations, not always mastered by the average cataract surgeon. However, flexible open-loop AC-IOLs are easier and faster to implant in the anterior chamber, and vitreous manipulation is usually not necessary?6 Eleven eyes (50%) in our study required vitrectomy for vitreous loss during secondary lens implantation. When vitreous is lost during cataract surgery, sufficient and painstaking vitreous cleaning is necessary to obtain more favourable results in secondary and especially primary AC-IOL implantation.
In conclusion, using an open-loop, flexible AC-IOL for both primary and secondary implantation is a suitable way to treat aphakia. On the basis of this study, secondary implantation of flexible open-loop AC-IOLs after ICCE seems to have more favourable visual outcomes and lower complication rates overall than primary implantation. Further studies including larger series and longer follow-up may help us to draw this conclusion more clearly.
